13F filer · CIK 1471149
Ayer Capital Management, LP
SAN FRANCISCO, CA · filing since Q2 2013 · last filing Aug 14, 2015
Reported value
$26.8M
$-41.4M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $25.5M
Top-10 weight
100.0%
Biggest buys vs Q1 2015
No new or increased positions this quarter.
Biggest sells vs Q1 2015
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | LION BIOTECHNOLOGIES INC | -2,780,682 | -49.6% | $-25.5M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2015
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LION BIOTECHNOLOGIES INCCOM | 2,823,333 | $25.9M | 96.51% |
| 2 | ONCOTHYREON INCCOM | 250,000 | $935.0K | 3.49% |